One in ten emergency patients with visible blood in their urine die within three months of presenting at A&E, new research has found.

One in ten emergency patients with visible blood in their urine dies within three months of presenting at hospital emergency ...

Patients in A&E who are offered scans and investigations within 48 hours have far better chances of survival, study finds ...

Keenova Therapeutics plc, a leading global developer and manufacturer of branded therapeutics, announced today that it will report its fourth-quarter 2025 financial results on Tuesday, March 31, 2026, ...

Dr. Jones is widely regarded as one of the most accomplished prosthetic surgeons in the nation, with over 30 years of clinical experience.

One in ten emergency patients with visible blood in their urine die within three months of presenting at A&E, new research has found.The WASHOUT ...

Government advisors have called for more support in tackling ketamine-related harms, and a national alert on its public ...

Having a prostate-specific antigen (PSA) test result above 4.0 ng/mL is considered abnormal and it is worth closer testing, a physician said yesterday, as he suggested individuals with a family ...

Padeliporfin VTP has demonstrated safety and efficacy for upper tract urothelial carcinoma treatment in a phase 1 study. Padeliporfin VTP is a combination product of a drug, padeliporfin administered ...

Co., Ltd. (Healinno Tech), an innovator in AI-powered surgical robotics, has introduced the metaFlow® Waterjet ...

This is the largest real-world analysis of mycophenolic acid in pediatric lupus nephritis to date, providing a decision-support system to help balance efficacy and safety.

Kevina O’Rourke is one of over 2,500 patients who were cared for from the comfort of their own homes under the virtual service launched in 2024 ...